A meeting to advance cancer biology through collaboration and innovation.
Official title: Systems Approaches to Cancer Biology Meeting
Funded at University of Colorado Denver · NIH-10904271 · Data updated 2026-11-12
This meeting brings together scientists and new researchers to share ideas and discoveries about cancer, helping them work together to better understand and tackle this complex disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | July 11, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $25,400 |
| NIH project number | 1R13CA291000-01 |
| Project ID | NIH-10904271 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would be early-stage cancer researchers and investigators looking to expand their knowledge and network in cancer systems biology.
✕Less likely to help
Patients who are not involved in cancer research or do not have a background in scientific investigation may not benefit from this meeting.
What this research studies
The Systems Approaches to Cancer Biology (SACB) meeting gathers scientific leaders and early-stage researchers to discuss and share advancements in cancer systems biology. This event focuses on the complexity of cancer, emphasizing the need for diverse scientific approaches to understand its multifactorial nature. Attendees participate in plenary sessions, poster presentations, and networking opportunities, including mentorship from experienced investigators. The meeting aims to foster collaboration and inspire new ideas in the field of cancer research.
Why it matters
Potential benefit: If successful, this research could enhance collaboration and innovation in cancer biology, leading to improved understanding and treatment of cancer.
How similar studies have gone: Previous SACB meetings have successfully fostered collaboration and innovation in cancer research, indicating a strong potential for continued success.
Where this research is happening
-
University of Colorado Denver
Aurora, United States Active
Researchers
- Principal investigator: Costello, James Christopher — University of Colorado Denver
- Study coordinator: Costello, James Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.